MediciNova is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. market.
2025/3/13 2:17:39
(MNOV:NASDAQ)
Analyst coverage
Streetwise Reports Articles